SBC Medical Group Holdings (SBC) Ratios

26 Followers

SBC Medical Group Holdings Ratios

SBC's free cash flow for Q4 2025 was $0.73. For the 2025 fiscal year, SBC's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23
Liquidity Ratios
Current Ratio	3.78	3.78	3.01	1.79
Quick Ratio	3.74	3.74	2.99	1.76
Cash Ratio	2.68	2.68	2.04	1.11
Solvency Ratio	0.46	0.46	0.71	0.45
Operating Cash Flow Ratio	0.64	0.64	0.34	0.55
Short-Term Operating Cash Flow Coverage	2.85	2.85	167.23	14.37
Net Current Asset Value	$ 114.08M	$ 114.08M	$ 113.39M	$ 50.91M
Leverage Ratios
Debt-to-Assets Ratio	0.14	0.14	0.05	0.09
Debt-to-Equity Ratio	0.21	0.21	0.06	0.16
Debt-to-Capital Ratio	0.17	0.17	0.06	0.14
Long-Term Debt-to-Capital Ratio	0.12	0.12	0.03	0.08
Financial Leverage Ratio	1.53	1.53	1.36	1.82
Debt Service Coverage Ratio	3.48	2.84	333.72	14.24
Interest Coverage Ratio	420.26	420.26	2.48K	1.56K
Debt to Market Cap	0.14	0.11	0.01	0.02
Interest Debt Per Share	0.50	0.50	0.13	0.24
Net Debt to EBITDA	-1.42	-1.60	-1.46	-0.93
Profitability Margins
Gross Profit Margin	72.91%	73.32%	75.97%	70.94%
EBIT Margin	44.04%	38.87%	35.77%	38.04%
EBITDA Margin	45.57%	40.42%	37.62%	44.37%
Operating Profit Margin	38.87%	38.87%	34.23%	36.51%
Pretax Profit Margin	47.27%	47.27%	35.76%	38.02%
Net Profit Margin	29.37%	29.37%	22.69%	20.34%
Continuous Operations Profit Margin	29.40%	29.40%	22.73%	19.92%
Net Income Per EBT	62.13%	62.13%	63.46%	53.51%
EBT Per EBIT	121.60%	121.60%	104.48%	104.13%
Return on Assets (ROA)	13.40%	13.40%	17.52%	15.21%
Return on Equity (ROE)	21.08%	20.54%	23.89%	27.69%
Return on Capital Employed (ROCE)	21.13%	21.13%	34.31%	42.48%
Return on Invested Capital (ROIC)	12.61%	12.61%	21.34%	21.31%
Return on Tangible Assets	16.07%	16.07%	17.94%	16.72%
Earnings Yield	14.71%	11.49%	8.68%	3.87%
Efficiency Ratios
Receivables Turnover	3.30	3.30	4.26	3.64
Payables Turnover	2.67	2.63	3.40	2.12
Inventory Turnover	16.84	16.59	33.02	18.19
Fixed Asset Turnover	10.61	10.61	14.63	9.92
Asset Turnover	0.46	0.46	0.77	0.75
Working Capital Turnover Ratio	0.98	1.18	2.09	4.55
Cash Conversion Cycle	-4.60	-6.37	-10.78	-51.94
Days of Sales Outstanding	110.62	110.62	85.63	100.20
Days of Inventory Outstanding	21.67	22.00	11.05	20.06
Days of Payables Outstanding	136.89	138.99	107.46	172.20
Operating Cycle	132.29	132.62	96.69	120.26
Cash Flow Ratios
Operating Cash Flow Per Share	0.38	0.38	0.21	0.54
Free Cash Flow Per Share	0.36	0.35	0.18	0.42
CapEx Per Share	0.02	0.02	0.04	0.12
Free Cash Flow to Operating Cash Flow	0.94	0.94	0.83	0.78
Dividend Paid and CapEx Coverage Ratio	16.42	16.42	6.04	4.52
Capital Expenditure Coverage Ratio	16.42	16.42	6.04	4.52
Operating Cash Flow Coverage Ratio	0.75	0.75	1.69	2.21
Operating Cash Flow to Sales Ratio	0.22	0.22	0.10	0.26
Free Cash Flow Yield	10.54%	8.23%	3.20%	3.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	6.74	8.71	11.52	25.84
Price-to-Sales (P/S) Ratio	1.98	2.56	2.61	5.26
Price-to-Book (P/B) Ratio	1.38	1.79	2.75	7.16
Price-to-Free Cash Flow (P/FCF) Ratio	9.40	12.15	31.26	25.80
Price-to-Operating Cash Flow Ratio	8.83	11.41	26.08	20.09
Price-to-Earnings Growth (PEG) Ratio	-10.00T>	2.43	0.74	0.02
Price-to-Fair Value	1.38	1.79	2.75	7.16
Enterprise Value Multiple	2.93	4.73	5.49	10.91
Enterprise Value	234.57M	331.78M	424.05M	937.12M
EV to EBITDA	2.97	4.73	5.49	10.91
EV to Sales	1.35	1.91	2.06	4.84
EV to Free Cash Flow	6.42	9.08	24.69	23.76
EV to Operating Cash Flow	6.03	8.52	20.60	18.50
Tangible Book Value Per Share	1.95	1.94	1.96	1.28
Shareholders’ Equity Per Share	2.42	2.41	2.02	1.51
Tax and Other Ratios
Effective Tax Rate	0.38	0.38	0.36	0.48
Revenue Per Share	1.69	1.69	2.13	2.05
Net Income Per Share	0.50	0.50	0.48	0.42
Tax Burden	0.62	0.62	0.63	0.54
Interest Burden	1.07	1.22	1.00	1.00
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.33	0.34	0.34	0.34
Stock-Based Compensation to Revenue	0.00	0.00	0.06	0.00
Income Quality	0.76	0.76	0.44	1.29

Currency in USD